Paper36765618
Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma.
Paris EA and 3 others. Cancers (Basel), 2023. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma. Papers, record 36765618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36765618
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA210370 | NCI NIH HHS | United States | R01CA210370 | PubMed and NIH |
| R01 CA210370 | National Institutes of Health | R01CA210370 | PubMed and NIH |
Source NIH RePORTER
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32132118 | Reducing Ovarian Cancer Mortality Through Early Detection: Approaches Using Circulating Biomarkers. | Cancer Prev Res (Phila) | 2020 | https://conductscience.org/library/papers/32132118 | PubMed |
| 2 | 28751161 | New perspectives of physiological and pathological functions of nucleolin (NCL). | Life Sci | 2017 | https://conductscience.org/library/papers/28751161 | PubMed |
| 3 | 34314463 | Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer. | PLoS One | 2021 | https://conductscience.org/library/papers/34314463 | PubMed |
| 4 | 19509547 | Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. | Int J Gynecol Cancer | 2009 | https://conductscience.org/library/papers/19509547 | PubMed |
| 5 | 3470736 | Nucleolin, the major nucleolar protein of growing eukaryotic cells: an unusual protein structure revealed by the nucleotide sequence. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3470736 | PubMed |
| 6 | 28825178 | Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature. | Med Oncol | 2017 | https://conductscience.org/library/papers/28825178 | PubMed |
| 7 | 25698534 | The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma. | Med Oncol | 2015 | https://conductscience.org/library/papers/25698534 | PubMed |
| 8 | 22433872 | Interactions of nucleolin and ribosomal protein L26 (RPL26) in translational control of human p53 mRNA. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22433872 | PubMed |
| 9 | 28153390 | Nucleolin Staining May Aid in the Identification of Circulating Prostate Cancer Cells. | Clin Genitourin Cancer | 2017 | https://conductscience.org/library/papers/28153390 | PubMed |
| 10 | 23599269 | Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex. | Blood | 2013 | https://conductscience.org/library/papers/23599269 | PubMed |
| 11 | 25294846 | VEGFR2-Targeted Ultrasound Imaging Agent Enhances the Detection of Ovarian Tumors at Early Stage in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer. | Ultrason Imaging | 2015 | https://conductscience.org/library/papers/25294846 | PubMed |
| 12 | 22937178 | Expression of death receptor 6 by ovarian tumors in laying hens, a preclinical model of spontaneous ovarian cancer. | Transl Oncol | 2012 | https://conductscience.org/library/papers/22937178 | PubMed |
| 13 | 25015231 | Cell surface protein C23 affects EGF-EGFR induced activation of ERK and PI3K-AKT pathways. | J Mol Neurosci | 2015 | https://conductscience.org/library/papers/25015231 | PubMed |
| 14 | 2566509 | Quantitation and subcellular localization of proliferating cell nuclear antigen (PCNA/cyclin) in oocytes and eggs of Xenopus laevis. | Exp Cell Res | 1989 | https://conductscience.org/library/papers/2566509 | PubMed |
| 15 | 27013428 | Nuclear envelope rupture and repair during cancer cell migration. | Science | 2016 | https://conductscience.org/library/papers/27013428 | PubMed |
| 16 | 20075200 | BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines. | Am J Pathol | 2010 | https://conductscience.org/library/papers/20075200 | PubMed |
| 17 | 19587342 | Clinical practice. Screening for ovarian cancer. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19587342 | PubMed |
| 18 | 26161406 | Interleukin 16- (IL-16-) Targeted Ultrasound Imaging Agent Improves Detection of Ovarian Tumors in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/26161406 | PubMed |
| 19 | 35497879 | Changes in IL-16 Expression in the Ovary during Aging and Its Potential Consequences to Ovarian Pathology. | J Immunol Res | 2022 | https://conductscience.org/library/papers/35497879 | PubMed |
| 20 | 31412132 | Inhibiting nucleolin reduces inflammation induced by mitochondrial DNA in cardiomyocytes exposed to hypoxia and reoxygenation. | Br J Pharmacol | 2019 | https://conductscience.org/library/papers/31412132 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 37958473 | Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37958473 |
Source PubMed
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| FAS | 355 | PubTator's text mining | https://conductscience.org/library/genes/355 | NCBI Gene |
| FASLG | 356 | PubTator's text mining | https://conductscience.org/library/genes/356 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP7 | 4316 | PubTator's text mining | https://conductscience.org/library/genes/4316 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
| MUC16 | 94025 | PubTator's text mining | https://conductscience.org/library/genes/94025 | NCBI Gene |
| NUCLEOLIN | 4691 | PubTator's text mining | https://conductscience.org/library/genes/4691 | NCBI Gene |
| PCNA | 5111 | PubTator's text mining | https://conductscience.org/library/genes/5111 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36765618
GET https://conductscience.org/api/papers/v1/36765618/references?page=2